1. Home
  2. OXBR vs VVOS Comparison

OXBR vs VVOS Comparison

Compare OXBR & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxbridge Re Holdings Limited

OXBR

Oxbridge Re Holdings Limited

HOLD

Current Price

$1.59

Market Cap

8.1M

Sector

Finance

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.40

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXBR
VVOS
Founded
2013
2016
Country
Cayman Islands
United States
Employees
4
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
9.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
OXBR
VVOS
Price
$1.59
$0.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$2.75
AVG Volume (30 Days)
58.8K
464.0K
Earning Date
05-11-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.76
EPS
N/A
N/A
Revenue
N/A
$17,443,000.00
Revenue This Year
$80.09
$69.66
Revenue Next Year
$85.22
$48.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.05
52 Week Low
$0.66
$0.38
52 Week High
$2.85
$5.95

Technical Indicators

Market Signals
Indicator
OXBR
VVOS
Relative Strength Index (RSI) 70.47 35.94
Support Level $1.51 $0.38
Resistance Level $2.09 $0.55
Average True Range (ATR) 0.17 0.05
MACD 0.03 0.00
Stochastic Oscillator 72.04 5.57

Price Performance

Historical Comparison
OXBR
VVOS

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer that provides reinsurance solutions through its subsidiary. The company focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. It specializes in underwriting medium-frequency, high-severity risks where insufficient data exists to effectively analyze the risk/return profile of reinsurance contracts. The company generates revenue from three principal sources: premiums assumed from reinsurance on property and casualty business; income from investments, including unrealized gains or losses on other investments; and income from SurancePlus management fees.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: